The goal of this clinical trial is to compare a standard adolescent-only approach to substance use screening, brief intervention, and referral to treatment to a in primary care settings. Primary outcomes (AOD use, co-occurring behavior problems, parent-youth communication about AOD use) and secondary outcomes (adolescent quality of life, therapy attendance) are assessed at screen/initial and 3, 6, 9, and 12 months follow-up.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Assessment of Liability and Exposure to Substance use and Antisocial Behavior (ALEXSA; Ridenour et al., 2009)
Timeframe: Initial and 3, 6, 9, and 12 months follow-up
Change in Youth Risk Index (ALEXSA; Ridenour et al., 2009)
Timeframe: Initial and 3, 6, 9, and 12 months follow-up
Change in Brief Problem Monitor (BPM; Achenbach & Rescorla, 2001)
Timeframe: Initial and 3, 6, 9, and 12 months follow-up
Change in Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0; Children's Hospital and Health Center, San Diego, CA)
Timeframe: Initial and 3, 6, 9, and 12 months follow-up
Change in Services Assessment for Children and Adolescents (SACA; Stiffman et al., 2000)
Timeframe: Initial and 3, 6, 9, and 12 months follow-up
Change in Parent-Teen Alcohol and Other Drug Use Communication Frequency (Koning et al., 2014)
Timeframe: Initial and 3, 6, 9, and 12 months follow-up
Change in Parent-Teen Alcohol and Other Drug Use Communication Quality (Spijkerman et al., 2008)
Timeframe: Initial and 3, 6, 9, and 12 months follow-up